Estrella Immunopharma Activates University Hospitals Cleveland Medical Center as Fourth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma August 11, 2026
Syntec Optics (Nasdaq: OPTX) Secures Fusion Energy Order as AI Data Center Orders Top $4M August 3, 2026